Analytical Data
-
Gene name
NTAQ1
- Application
-
Alternative Names
NTAQ1；C8orf32；WDYHV1；Protein N-terminal glutamine amidohydrolase
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q96HA8
-
Expression Region
1-205aa
-
AA Sequence
MEGNGPAAVH YQPASPPRDA CVYSSCYCEE NIWKLCEYIK NHDQYPLEEC YAVFISNERK MIPIWKQQAR PGDGPVIWDY HVVLLHVSSG GQNFIYDLDT VLPFPCLFDT YVEDAFKSDD DIHPQFRRKF RVIRADSYLK NFASDRSHMK DSSGNWREPP PPYPCIETGD SKMNLNDFIS MDPKVGWGAV YTLSEFTHRF GSKNC
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
NTAQ1 (N-terminal arginine-rich protein 1) is a member of a family of proteins that have gained significant interest in recent years due to their potential roles in cellular processes and disease mechanisms. The study of NTAQ1 is particularly relevant in the context of various biological functions, including RNA binding, stress response, and regulation of gene expression. Research has identified NTAQ1 as being involved in the cellular response to stressors, which may implicate it in signal transduction pathways and dysfunctions observed in various diseases, including neurodegenerative disorders and cancer. The recombinant expression of NTAQ1 allows for the detailed exploration of its biochemical properties, interactions with other cellular components, and potential therapeutic applications. By producing NTAQ1 in a recombinant system, researchers can analyze its structure-function relationship, providing insights into how alterations in its function could contribute to pathologies. Moreover, understanding NTAQ1's role in cellular processes facilitates the identification of novel drug targets and biomarkers for disease. Ongoing studies focused on NTAQ1 are expected to elucidate its mechanisms of action, paving the way for therapeutic innovations and enhancing our overall understanding of cellular biology and disease pathology. As the research progresses, it promises to contribute valuable knowledge regarding the implications of NTAQ1 in health and disease, reinforcing the significance of this protein in modern biomedical research.
